Tristel plc (AIM:TSTL)
London · Delayed Price · Currency is GBP · Price in GBX 417.50
+7.50 (1.83%)
Dec 31, 2025, 12:19 PM GMT+1
Tristel Market Cap
Tristel has a market cap or net worth of 199.34 million as of December 31, 2025. Its market cap has increased by 7.59% in one year.
Market Cap
199.34M
Enterprise Value
192.38M
Revenue
46.46M
Ranking
n/a
PE Ratio
30.19
Stock Price
417.50
Market Cap Chart
Since June 1, 2005, Tristel's market cap has increased from 6.91M to 199.34M, an increase of 2,786.11%. That is a compound annual growth rate of 17.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 199.34M | -1.65% |
| Dec 31, 2024 | 202.69M | -7.08% |
| Dec 29, 2023 | 218.13M | 18.41% |
| Dec 30, 2022 | 184.21M | -14.20% |
| Dec 31, 2021 | 214.69M | -12.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.19B |
| GSK plc | 73.15B |
| Haleon | 33.22B |
| Smith & Nephew | 10.43B |
| Convatec Group | 4.74B |
| Hikma Pharmaceuticals | 3.40B |
| Genus | 1.73B |
| HUTCHMED (China) | 1.71B |